Skip to content

Determined Cancer Scientist Crafts 'Golden Particles' through Bravery and Teamwork

At 23, Scott Gerber, a Dunkin Donuts cashier, found himself struggling in a master's program at our medical center. However, driven by a passion for immunology, he took a daring leap, which subsequently led to a prosperous career at Wilmot.

Scientist Creates 'Gold Dust' from Courage and Teamwork in Cancer Research
Scientist Creates 'Gold Dust' from Courage and Teamwork in Cancer Research

Determined Cancer Scientist Crafts 'Golden Particles' through Bravery and Teamwork

In the world of cancer research, Scott Gerber is making waves with his groundbreaking work and innovative approaches. His journey began in an unexpected place – a veterinary practice in Niagara Falls, where he first developed his fascination with science.

Gerber's career took a significant leap when Edith Lord, a prominent immunologist, saw potential in him and hired him as a technician in her lab. This move set his career in motion, leading him to complete his Ph.D. at Loyola University Chicago.

At the age of 23, Gerber was a cashier at Dunkin Donuts and a student in a master's program at the University of Rochester Medical Center. Despite the challenges, he took a risk and signed up for an advanced seminar on immunology taught by Edith Lord.

During his graduate studies, Gerber made a significant discovery – a new technique for looking at tumors called "whole mount histology." This breakthrough would prove instrumental in his future research.

After receiving his Ph.D. in 2005, Gerber ventured to Yale University as a post-doc with his wife and infant son. There, he won a fellowship in cancer research and published several papers in scientific journals.

Returning to Rochester Medical Center, Gerber met David Linehan, who became his next stalwart supporter and mentor. Linehan promoted Gerber into a tenure-track position, and together they formed the Linehan/Gerber research powerhouse at Wilmot.

Their collaborative efforts have resulted in numerous breakthroughs, including a new clinical trial that combines radiation therapy and immune therapy, using a new drug-delivery system called microspheres, to destroy pancreatic tumors with fewer side effects.

This latest project has secured Gerber and his mentor, David Linehan, M.D., Wilmot's director of clinical operations, a $2.6 million NCI grant. This funding will further propel their research and potentially revolutionise the treatment of pancreatic cancer.

Scott Gerber is not only a trailblazer in his field but also dedicated to teaching and mentoring young clinicians and scientists. His story serves as an inspiration to many, demonstrating that with determination and a passion for science, one can overcome obstacles and make significant contributions to the world of medicine.

Read also:

Latest